Potent cannabis linked to surging schizophrenia cases - New schizophrenia cases linked to cannabis use disorder more than doubled in Ontario after legalisation of drug ...

NXE-0048149 is under clinical development by Nxera Pharma and currently in Phase I for Schizophrenia. According to GlobalData ... MC4 Antagonist, GLP-1 agonist, Dual Muscarinic M1 and M4 Agonists, ...

That year, it saw 55,782 patients, of whom nearly 15,000 patients with schizophrenia had an inpatient admission or made outpatient visits. Overall, it had 27,200 patients with a diagnosis of ...

SINGAPORE - “When all is said and done, they are stranger to me than the birds in my garden,” said Swiss psychiatrist Eugen Bleuler of his patients with schizophrenia. It was Dr Bleuler who ...

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...

Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...

Catatonic schizophrenia is one feature of a serious ... but doctors look for at least three of the following to make a diagnosis: Research shows that many people with catatonia are aware ...

Abstract: In this paper, a fault diagnosis scheme is developed for open-circuit faults in dual three-phase permanent magnet synchronous motor (DTP-PMSM) drives based on adaptive fault-tolerant control ...

To overcome these issues, this article proposes an enhanced partial transfer fault diagnosis network with dual-force boundary refinement (DFBR) and inverse-forward adaptive alignment (IFAA). First, ...